Published in TB and Outbreaks Week, June 10th, 2003
[helv]In our March 12, 2003, shareholder letter we outlined our plans for the next 12 months. Management is confident that Cel-Sci is on target to achieve and exceed its goals, as explained below.
The company's president and the company's CEO feel that Cel-Sci has now made such significant advances that we recently elected to take 6 months of stock in lieu of salary (shares restricted from sale for 1 year). We did so because we have confidence in the company's employees and in the science. Equally important,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.